Search

everythinglearnresearchcommunity

for

Search:↓

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Hair disorders need a holistic approach, including medical, cosmetic, and psychological support.

Particles around 100 nm can penetrate and stay in hair follicles without passing through healthy skin, making them safe for use in topical products and useful for targeted drug delivery.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Minoxidil promotes hair growth but stops working when discontinued.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Iontophoresis improves minoxidil delivery to hair follicles for hair loss treatment.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

Topical antiandrogens might treat skin issues like hair growth, balding, and acne, but finding effective treatments without side effects is challenging.

Dutasteride-loaded nanoparticles coated with Lauric Acid-Chitosan show promise for treating hair loss due to their controlled release, low toxicity, and potential to stimulate hair growth.

There is an urgent need for better treatments for hair loss caused by chemotherapy.

Some extracts from woods and fungi can promote hair growth better than a known hair growth substance.

Biologicals are increasingly used in medicine and cosmetics, especially for skin and hair treatments, but more research is needed.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Multiple treatments work best for hair loss.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

Researchers developed a model that shows hair follicles increase skin absorption of caffeine by 20%.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

The conclusion is that measuring how drugs partition into artificial sebum is important for predicting their delivery into hair and sebaceous follicles, and it provides better information than traditional methods.

Oleic acid nanovesicles improve minoxidil absorption in hair follicles for alopecia treatment.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Minoxidil effectively treats hair loss, works better for women, and requires consistent use.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.